Could plasma based therapies still be considered in selected cases with atypical hemolytic uremic syndrome?

Could plasma based therapies still be considered in selected cases with atypical hemolytic uremic syndrome?

Background. Atypical hemolytic uremic syndrome (aHUS) occurs due to defective regulation of the alternative complement pathway (ACP) on vascular endothelial cells. Plasma based therapy (PT) was the mainstay of the treatment for aHUS for many years until the introduction of therapies targeting...

Full description

Bibliographic Details
Main Authors: Sare Gülfem Özlü, Oğuz Söylemezoğlu, Rezan Topaloğlu, Zeynep Birsin Özçakar, Banu Acar, Mehmet Taşdemir, Elif Çomak, Elif Bahat Özdoğan, Gönül Parmaksız, Ali Delibaş, Emine Atayar, Özlem Aydoğ, Bora Gülhan, Fatih Özaltın
Format: Article
Language:English
Published: Hacettepe University Institute of Child Health 2021-12-01
Series:The Turkish Journal of Pediatrics
Subjects:
atypical hemolytic uremic syndrome
outcome
plasma exchange
plasma infusion
treatment
Online Access:https://turkjpediatr.org/article/view/386

Internet

https://turkjpediatr.org/article/view/386

Similar Items